drugset / Trial / NCT01369680

Oral Ketamine for Control of Chronic Pain in Children

NCT01369680

Phase 1 Completed 12 enrolled University of Rochester
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study is a maximum tolerated dose finding study for oral, chronic, daily administration of oral ketamine (by mouth) in children with long-term daily pain.

Timeline

Start
2011-05
Primary completion
2012-10
Completion
2012-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.25 mg/kg Oral
Subject Ketamine Small molecule 0.5 mg/kg Oral
Subject Ketamine Small molecule 1 mg/kg Oral
Subject Ketamine Small molecule 1.5 mg/kg Oral

Indications